AAD
  • Registration
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Topics
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Resources
  • Registration
Facebook iconInstagram iconTwitter icon
Mar 07, 2022

Learn more about AAD’s DEI efforts in new session

Explore all of dermatology's initiatives.


Left to right: Kanade Shinkai, MD, PhD, FAAD, and Henry W. Lim, MD, FAAD.
Left to right: Kanade Shinkai, MD, PhD, FAAD, and Henry W. Lim, MD, FAAD.

S023 – Diversity, Equity, and Inclusion

Saturday, March 26 | 9 a.m. – 12 p.m.

Room: 153C

A new session will highlight efforts the Academy and other organizations in dermatology have made to address diversity, equity, and inclusion (DEI) in the specialty, along with discussion about what needs to be done to achieve the goal of greater diversity.

Kanade Shinkai, MD, PhD, FAAD, a dermatologist with the University of California San Francisco Health, and Henry W. Lim, MD, FAAD, AAD past-president and dermatologist at Henry Ford Hospital in Detroit will co-chair the new session, S023 – Diversity, Equity, and Inclusion, which will cover key initiatives of dermatology organizations to promote DEI in the specialty.

A lack of DEI in the specialty has a potential direct impact on the daily work of dermatologists as well as every key mission of the work they do, Dr. Lim said. This impact will be addressed in the session, including discussion of:

  • Patient access to dermatologic care.
  • Accurate diagnosis of skin disease, skin cancer, and evidence-based treatment.
  • Representation within the dermatology workforce as well as the geographic distribution of dermatologists.
  • Representation within dermatology leadership.
  • Educating the next generation of dermatologists to become experts of skin, hair, and nail disease in all individuals.
  • Inclusion of diverse populations in research and clinical trials.

Drs. Shinkai and Lim will also present the latest AAD initiatives, combined with a wide spectrum of mentorships, sponsorships, allyship building, research, education, advocacy, and leadership in dermatology that will help dermatologists move the needle toward improved DEI and patient care. Don’t miss this important opportunity to learn more.

Visit AAD DermWorld Meeting News Central for more articles.

Interesting Stories
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
Presented by Pfizer Inc.
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
Advancing Therapeutic Conversations
Presented by AbbVie
Advancing Therapeutic Conversations
Join Us to Learn More About SOTYKTU<sup>TM</sup> (deucravacitinib):
Presented by Bristol Myers Squibb
Join Us to Learn More About SOTYKTUTM (deucravacitinib):
What makes a biosimilar and an Interchangeable biosimilar different?
Presented by Boehringer Ingelheim
What makes a biosimilar and an Interchangeable biosimilar different?
Janssen-Sponsored Symposium
Presented by Janssen Biotech, Inc.
Janssen-Sponsored Symposium
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Presented by Neutrogena
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Prurigo Nodularis and Atopic Dermatitis:
Presented by Sanofi and Regeneron Pharmaceuticals, Inc.
Prurigo Nodularis and Atopic Dermatitis:
More in AAD 2022 Annual Meeting
Aad Ia22 Welcome Guide Cover
2022 AAD Innovation Academy
Your Welcome Guide to Innovation Academy
Jul 13, 2022
AAD
Facebook iconInstagram iconTwitter icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.